{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T23:15:17Z","timestamp":1725578117948},"publisher-location":"Berlin, Heidelberg","reference-count":58,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642008177"},{"type":"electronic","value":"9783642008184"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-642-00818-4_5","type":"book-chapter","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T05:27:58Z","timestamp":1297315678000},"page":"59-135","source":"Crossref","is-referenced-by-count":0,"title":["Primary Grey Matter Loss"],"prefix":"10.1007","author":[{"given":"Frederik","family":"Barkhof","sequence":"first","affiliation":[]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio J.","family":"Bastos-Leite","sequence":"additional","affiliation":[]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,10,20]]},"reference":[{"key":"5_CR1_5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67\u201377","journal-title":"Nat Rev Neurol"},{"key":"5_CR2_5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1212\/01.wnl.0000344568.09360.31","volume":"72","author":"WJP Henneman","year":"2009","unstructured":"Henneman WJP, Sluimer JD, Barnes J et al (2009) Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology 72:999\u20131007","journal-title":"Neurology"},{"key":"5_CR3_5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9:119\u2013128","journal-title":"Lancet Neurol"},{"key":"5_CR4_5","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"RJ Perrin","year":"2009","unstructured":"Perrin RJ, Fagan AM, Holtzman DM (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease. Nature 461:916\u2013922","journal-title":"Nature"},{"issue":"4","key":"5_CR5_5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","volume":"9","author":"JO Rinne","year":"2010","unstructured":"Rinne JO, Brooks DJ, Rossor MN et al (2010) 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer\u2019s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol 9(4):363\u201372","journal-title":"Lancet Neurol"},{"issue":"1","key":"5_CR6_5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1474-4422(02)00002-9","volume":"1","author":"P Scheltens","year":"2002","unstructured":"Scheltens P, Fox N, Barkhof F, De Carli C (2002) Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 1(1):13\u201321","journal-title":"Lancet Neurol"},{"key":"5_CR7_5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2967\/jnumed.108.056499","volume":"50","author":"N Tolboom","year":"2009","unstructured":"Tolboom N, Yaqub M, van der Flier WM, Boellaard R, Luurtsema G, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN (2009) Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. J Nucl Med 50:191\u2013197","journal-title":"J Nucl Med"},{"issue":"Pt 11","key":"5_CR8_5","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1093\/brain\/awl285","volume":"129","author":"AL Adlam","year":"2006","unstructured":"Adlam AL, Patterson K, Rogers TT, Nestor PJ, Salmond CH, Acosta-Cabronero J, Hodges JR (2006) Semantic dementia and fluent primary progressive aphasia: two sides of the same coin? Brain 129(Pt 11):3066\u201380","journal-title":"Brain"},{"issue":"1","key":"5_CR9_5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IR et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol (Berl) 114(1):5\u201322, Epub 2007 Jun 20","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"5_CR10_5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.92","volume":"49","author":"D Chan","year":"2001","unstructured":"Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN (2001) Patterns of temporal lobe atrophy in semantic dementia and Alzheimer\u2019s disease. Ann Neurol 49(4):433\u201342","journal-title":"Ann Neurol"},{"issue":"3","key":"5_CR11_5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ana.10825","volume":"55","author":"ML Gorno-Tempini","year":"2004","unstructured":"Gorno-Tempini ML, Dronkers NF, Rankin KP et al (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55(3):335\u201346","journal-title":"Ann Neurol"},{"issue":"1","key":"5_CR12_5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Neumann M, Bigio EH et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119(1):1\u20134","journal-title":"Acta Neuropathol"},{"issue":"11","key":"5_CR13_5","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","volume":"58","author":"GM McKhann","year":"2001","unstructured":"McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, Work Group on Frontotemporal Dementia and Pick\u2019s Disease (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick\u2019s Disease. Arch Neurol 58(11):1803\u20139","journal-title":"Arch Neurol"},{"issue":"6","key":"5_CR14_5","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51(6):1546\u201354","journal-title":"Neurology"},{"issue":"18","key":"5_CR15_5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1212\/WNL.0b013e3181bf997a","volume":"73","author":"JD Rohrer","year":"2009","unstructured":"Rohrer JD, Guerreiro R, Vandrovcova J et al (2009) The heritability and genetics of frontotemporal lobar degeneration. Neurology 73(18):1451\u20136","journal-title":"Neurology"},{"issue":"4","key":"5_CR16_5","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WAD.0b013e31815c3445","volume":"21","author":"K Rascovsky","year":"2007","unstructured":"Rascovsky K, Hodges JR, Kipps CM et al (2007) Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord 21(4):S14\u20138","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"5_CR17_5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/0891988704267470","volume":"17","author":"D Aarsland","year":"2004","unstructured":"Aarsland D, Ballard CG, Halliday G (2004) Are Parkinson\u2019s disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 17(3):137\u2013145","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"5_CR18_5","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"issue":"4","key":"5_CR19_5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","volume":"6","author":"I McKeith","year":"2007","unstructured":"McKeith I, O\u2019Brien J, Walker Z et al (2007) Sensitivity and specificity of dopamine transporter imaging with I-123-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6(4):305\u2013313","journal-title":"Lancet Neurol"},{"issue":"10","key":"5_CR20_5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1212\/WNL.56.10.1386","volume":"56","author":"JT O\u2019Brien","year":"2001","unstructured":"O\u2019Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, Gholkar A, Crum WR, Rossor MN, Fox NC (2001) Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 56(10):1386\u20131388","journal-title":"Neurology"},{"issue":"6","key":"5_CR21_5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000264614","volume":"28","author":"R Watson","year":"2009","unstructured":"Watson R, Blamire AM, O\u2019Brien JT (2009) Magnetic resonance imaging in lewy body dementias. Dement Geriatr Cogn Disord 28(6):493\u2013506","journal-title":"Dement Geriatr Cogn Disord"},{"key":"5_CR22_5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/brain\/awl388","volume":"130","author":"JL Whitwell","year":"2007","unstructured":"Whitwell JL, Weigand SD, Shiung MM et al (2007) Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer\u2019s disease. Brain 130:708\u2013719","journal-title":"Brain"},{"issue":"6","key":"5_CR23_5","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","volume":"128","author":"DR Williams","year":"2005","unstructured":"Williams DR (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain 128(6):1247\u20131258","journal-title":"Brain"},{"issue":"3","key":"5_CR24_5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1212\/WNL.54.3.697","volume":"54","author":"A Schrag","year":"2000","unstructured":"Schrag A (2000) Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 54(3):697\u2013702","journal-title":"Neurology"},{"issue":"12","key":"5_CR25_5","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","volume":"64","author":"H Oba","year":"2005","unstructured":"Oba H (2005) New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 64(12):2050\u20132055","journal-title":"Neurology"},{"key":"5_CR26_5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1\u20139","journal-title":"Neurology"},{"key":"5_CR27_5","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/brain\/awh303","volume":"127","author":"T Ozawa","year":"2004","unstructured":"Ozawa T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657\u20132671","journal-title":"Brain"},{"key":"5_CR28_5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/brain\/awf117","volume":"125","author":"H Watanabe","year":"2002","unstructured":"Watanabe H (2002) Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 125:1070\u20131083","journal-title":"Brain"},{"key":"5_CR29_5","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00702-005-0332-2","volume":"112","author":"K Seppi","year":"2005","unstructured":"Seppi K (2005) How to diagnose MSA early: the role of magnetic resonance imaging18. J Neural Transm 112:1625\u20131634","journal-title":"J Neural Transm"},{"key":"5_CR30_5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","volume":"63","author":"EH Aylward","year":"2004","unstructured":"Aylward EH, Sparks BF, Field KM et al (2004) Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63:66\u201372","journal-title":"Neurology"},{"volume-title":"Huntington\u2019s disease","year":"2002","key":"5_CR31_5","unstructured":"Bates G, Harper PS et al (eds) (2002) Huntington\u2019s disease. Oxford University Press, New York"},{"key":"5_CR32_5","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/brain\/awm217","volume":"130","author":"A Feigin","year":"2007","unstructured":"Feigin A, Tang C, Ma Y et al (2007) Thalamic metabolism and symptom onset in preclinical Huntington\u2019s disease. Brain 130:2858\u201367","journal-title":"Brain"},{"key":"5_CR33_5","first-page":"1715","volume":"25","author":"JS Paulsen","year":"2004","unstructured":"Paulsen JS, Zimbelman JL, Hinton SC et al (2004) fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington\u2019s Disease. AJNR Am J Neuroradiol 25:1715\u20131721","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"5_CR34_5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1602\/neurorx.1.2.263","volume":"1","author":"HD Rosas","year":"2004","unstructured":"Rosas HD, Feigin AS et al (2004) Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington\u2019s disease. NeuroRx 1(2):263\u201372","journal-title":"NeuroRx"},{"issue":"6","key":"5_CR35_5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/WCO.0b013e3282f12074","volume":"20","author":"EJ Wild","year":"2007","unstructured":"Wild EJ, Tabrizi SJ (2007) Huntington\u2019s disease phenocopy syndromes. Curr Opin Neurol 20(6):681\u20137","journal-title":"Curr Opin Neurol"},{"key":"5_CR36_5","unstructured":"http:\/\/www.nbiadisorders.org\/"},{"key":"5_CR37_5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa020817","volume":"348","author":"SJ Hayflick","year":"2003","unstructured":"Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J (2003) Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 348:33\u201340","journal-title":"N Engl J Med"},{"issue":"2","key":"5_CR38_5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiology.198.2.8596862","volume":"198","author":"HN Wassenaer-van Hall van","year":"1996","unstructured":"van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, Hoogenraad TU, Mali WP (1996) Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 198(2):531\u20136","journal-title":"Radiology"},{"issue":"6","key":"5_CR39_5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mds.22689","volume":"25","author":"LK Prashanth","year":"2010","unstructured":"Prashanth LK, Sinha S, Taly AB, Vasudev MK (2010) Do MRI features distinguish Wilson\u2019s disease from other early onset extrapyramidal disorders? An analysis of 100 cases. Mov Disord 25(6):672\u20138","journal-title":"Mov Disord"},{"key":"5_CR40_5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/WNL.49.6.1605","volume":"49","author":"R Koide","year":"1997","unstructured":"Koide R, Onodera O, Ikeudu T et al (1997) Atrophy of the cerebellum and brain stem in dentatorubral-pallidoluysian atrophy: influence of GAG repeat size on MR findings. Neurology 49:1605\u20131612","journal-title":"Neurology"},{"key":"5_CR41_5","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1212\/WNL.50.6.1887","volume":"50","author":"H Tomiyasu","year":"1998","unstructured":"Tomiyasu H, Yoshii F, Ohnuki I, Ikeda JE, Shinohara Y (1998) The brainstem and thalamic lesions in dentatorubral-pallidoluysian atrophy: an MRI study. Neurology 50:1887\u20131890","journal-title":"Neurology"},{"issue":"9","key":"5_CR42_5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/crad.2001.0771","volume":"56","author":"DA Collie","year":"2001","unstructured":"Collie DA, Sellar RJ, Zeidler M, Colchester AC, Knight R, Will RG (2001) MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 56(9):726\u201339","journal-title":"Clin Radiol"},{"key":"5_CR43_5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3174\/ajnr.A1860","volume":"31","author":"H Hyare","year":"2010","unstructured":"Hyare H, Thornton J, Stevens J et al (2010) High-b-value diffusion MR imaging and basal nuclei apparent diffusion coefficient measurements in variant and sporadic Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol 31:521\u20136","journal-title":"AJNR Am J Neuroradiol"},{"key":"5_CR44_5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/bmb\/66.1.241","volume":"66","author":"JD Wadsworth","year":"2003","unstructured":"Wadsworth JD, Hill AF, Beck JA, Collinge J (2003) Molecular and clinical classification of human prion disease. Br Med Bull 66:241\u201354","journal-title":"Br Med Bull"},{"key":"5_CR45_5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jnnp.2006.094821","volume":"78","author":"RG Macfarlane","year":"2007","unstructured":"Macfarlane RG, Wroe SJ, Collinge J, Yousry TA, J\u00e4ger HR (2007) Neuroimaging findings in human prion disease. J Neurol Neurosurg Psychiatry 78:664\u201370","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5_CR46_5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1007\/s00330-006-0456-2","volume":"17","author":"HJ Tschampa","year":"2007","unstructured":"Tschampa HJ et al (2007) Radiological assessment of CJD. Eur Radiol 17:1200\u201311","journal-title":"Eur Radiol"},{"key":"5_CR47_5","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1212\/WNL.0b013e3181a96e5d","volume":"72","author":"B Meissner","year":"2009","unstructured":"Meissner B, Kallenberg K, Sanchez-Juan P et al (2009) MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 72:1994\u20132001","journal-title":"Neurology"},{"issue":"Suppl 1","key":"5_CR48_5","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1148\/rg.26si065503","volume":"26","author":"R Ukisu","year":"2006","unstructured":"Ukisu R, Kushihashi T, Tanaka E, Baba M, Usui N, Fujisawa H, Takenaka H (2006) Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations. Radiographics 26(Suppl 1):S191\u2013204","journal-title":"Radiographics"},{"key":"5_CR49_5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/brain\/awl303","volume":"130","author":"AJ Bartsch","year":"2007","unstructured":"Bartsch AJ, Homola G, Biller A, Smith SM, Weijers HG, Wiesbeck GA, Jenkinson M, De Stefano N, Solymosi L, Bendszus M (2007) Manifestations of early brain recovery associated with abstinence from alcoholism. Brain 130:36\u201347","journal-title":"Brain"},{"issue":"1","key":"5_CR50_5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0006-3223(03)00610-3","volume":"55","author":"AL Brody","year":"2004","unstructured":"Brody AL, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, Huang JC et al (2004) Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry 55(1):77\u201384","journal-title":"Biol Psychiatry"},{"issue":"8","key":"5_CR51_5","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1073\/pnas.061369098","volume":"98","author":"M Ernst","year":"2001","unstructured":"Ernst M, Matochik JA, Heishman SJ, Van Horn JD, Jons PH, Henningfield JE et al (2001) Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci USA 98(8):4728\u20134733","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"5_CR52_5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0161-813X(02)00109-2","volume":"24","author":"JS Fowler","year":"2003","unstructured":"Fowler JS, Logan J, Wang GJ, Volkow ND (2003) Monoamine oxidase and cigarette smoking. Neurotoxicology 24(1):75\u201382","journal-title":"Neurotoxicology"},{"issue":"6","key":"5_CR53_5","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1007\/s00330-009-1668-z","volume":"20","author":"S Geibprasert","year":"2009","unstructured":"Geibprasert S, Gallucci M, Krings T (2009) Alcohol-induced changes in the brain as assessed by MRI and CT. Eur Radiol 20(6):1492\u20131501, Epub ahead of print","journal-title":"Eur Radiol"},{"issue":"1","key":"5_CR54_5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coph.2004.10.002","volume":"42","author":"A Lingford-Hughes","year":"2005","unstructured":"Lingford-Hughes A (2005) Human brain imaging and substance abuse. Curr Opin Pharmacol 42(1):42\u20136, Review","journal-title":"Curr Opin Pharmacol"},{"key":"5_CR55_5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/15504260902869204","volume":"2","author":"FJ McClernon","year":"2009","unstructured":"McClernon FJ (2009) Neuroimaging of Nicotine Dependence: key findings and application to the study of smoking-mental illness comorbidity. J Dual Diagn 2:168\u2013178","journal-title":"J Dual Diagn"},{"key":"5_CR56_5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1136\/jnnp.2006.095869","volume":"78","author":"S Mechtcheriakov","year":"2007","unstructured":"Mechtcheriakov S, Brenneis C, Egger K, Koppelstaetter F, Schocke M, Marksteiner JA (2007) Widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry. J Neurol Neurosurg Psychiatry 78:610\u2013614","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"5_CR57_5","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.2967\/jnumed.108.050716","volume":"49","author":"AG Mukhin","year":"2008","unstructured":"Mukhin AG, Kimes AS, Chefer SI, Matochik JA, Contoreggi CS, Horti AG et al (2008) Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2\u201318F-FA-85380. J Nucl Med 49(10):1628\u20131635","journal-title":"J Nucl Med"},{"issue":"6","key":"5_CR58_5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1001\/archpsyc.65.6.694","volume":"65","author":"M Y\u00fccel","year":"2008","unstructured":"Y\u00fccel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman DI (2008) Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 65(6):694\u2013701","journal-title":"Arch Gen Psychiatry"}],"container-title":["Neuroimaging in Dementia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-00818-4_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T03:33:36Z","timestamp":1558409616000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-00818-4_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,20]]},"ISBN":["9783642008177","9783642008184"],"references-count":58,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-00818-4_5","relation":{},"subject":[],"published":{"date-parts":[[2010,10,20]]}}}